Home / M&A Activity / Parsons Buys Williams Electric in Control Tech Market Push; Chuck Harrington, Carey Smith Comment

Parsons Buys Williams Electric in Control Tech Market Push; Chuck Harrington, Carey Smith Comment

Parsons has purchased Williams Electric for an undisclosed sum as part of the Pasadena, California-based engineering services contractor’s move to expand its control systems business.

Fort Walton Beach, Florida-based Williams Electric is a privately held company that provides electrical, control system integration, general contracting and energy infrastructure platforms and services for defense and federal agency clients, Parsons said Tuesday.

Carey Smith

Chuck Harrington, Parsons chairman and CEO, said the acquisition is part of the company’s strategy to help protect operational technologies and other critical infrastructure assets from cyber threats.

“Parsons’ existing contractual relationships with numerous customers within the departments of Defense, Energy, and Veterans Affairs and elsewhere are ideal environments for our now expanded control system offering,” said Carey Smith, Parsons federal group president.

Smith, an inductee into Executive Mosaic’s Wash100 for 2017, said Parsons expects the acquisition to result in new opportunities and help expand its control systems market presence in the Middle East and other regions.

The $50 billion control system market is estimated to record a compound annual growth rate of at least 10 percent over the next five years.

Williams Electric runs offices in Maryland and Virginia and has employees at over 100 client sites both in the U.S. and overseas.

Check Also

F5 to Buy Shape Security for $1B; Francois Locoh-Donou Quoted

F5 Networks (Nasdaq: FFIV) has agreed to acquire Santa Clara, Calif.-based Shape Security for approximately $1B in cash as both companies aim to help government and enterprise customers secure digital experience with integrated offerings.

Paratek Secures $169M Anthrax Antibiotic Development Contract Under HHS Project BioShield

The Department of Health and Human Services has awarded Paratek Pharmaceuticals a potential a five-year, $169M contract to further develop an antibiotic drug as a potential treatment for inhalation anthrax.